1-2 of 2
Murugan Palanisamy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)

Sunil Bhat, Sharat Damodar, Pooja Mallya, Akshatha Nayak, Ravi Joshi, Bharath Ram S, Sudarshan Chougule, Deepak MB, Gopinadh Jakka, Sudeshna Dhar, Anne Roshan Joseph, Arun Kumar MG, Murugan Palanisamy, Jeetendra Kumar, Melina Soares, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat
Journal: Blood
Blood (2022) 140 (Supplement 1): 7478–7479.
https://doi.org/10.1182/blood-2022-166650
Published: 2022
Journal Articles

Early Results from a Phase-2 Study of Varnimcabtagene Autoleucel (IMN-003A), a First-in-India Industry CD19-Directed CAR-T Cell Therapy with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies (IMAGINE Study)

Sharat Damodar, Sunil Bhat, Akshatha Nayak, Pooja Mallya, Bharath Ram S, Ravi Joshi, Deepak MB, Sudarshan Chougule, Anne Roshan Joseph, Gopinadh Jakka, Sudeshna Dhar, Arun Kumar MG, Murugan Palanisamy, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Arun Anand, Anil Kamat
Journal: Blood
Blood (2022) 140 (Supplement 1): 10343–10344.
https://doi.org/10.1182/blood-2022-166297
Published: 2022